Cleerly

Cleerly is aware of the lawsuit filed by Heartflow. We are confident in our extensive and well-established intellectual property portfolio and the originality of our technology.

Cleerly has published landmark clinical science that has redefined how cardiovascular disease is understood and treated, which has formed the basis of our novel technologies that provide physicians with actionable insights into their patients’ heart health.

Cleerly was founded on a mission to create a world without heart attacks, and we have never been more focused in our mission and committed to the patients and physicians who count on us.

For any questions, please reach out to press@cleerlyhealth.com

Hubspot names Cleerly Among 40 AI Startups To Watch Out For in 2023

Hubspot, an industry-leading software provider of tools that link marketing, sales and customer service, names Cleerly as one of the top 40 startups...

Read More
MedTech Strategist - Cleerly Featured on the June 2022 Cover

MedTech Strategist: Cleerly’s Personalized Approach to Heart Attack Risk

In this interview, Cleerly Founder and CEO, James Min, MD, shares how despite advances in cardiology, most heart attacks occur without warning....

Read More

1 min read

Cleerly's AI scans comparable to gold-standard angiography

Only a few months after it emerged from stealth and burst onto the medtech scene, Cleerly is already living up to its name.

Read More

1 min read

Cleerly’s Technology | An Important Impact On Our Overall Wellness

Health Tech: Dr James Min On How Cleerly’s Technology Can Make An Important Impact On Our Overall Wellness An Interview With Dave Philistin

Read More

Cleerly launches updated heart disease software

Cleerly has launched Cleerly 2.2.0, a new version of its software that includes user experience improvements and three new tools.

Read More

1 min read

Cleerly Gains Three New Board Members

Latest additions worked for GE Healthcare, Humana, and Geisinger Health System. Cleerly has added three new members to its Board of Directors.

Read More

Cleerly names COO, CTO

The hires come in the wake of completing a $43 million series B round of funding this summer.

Read More

1 min read

Interview: Debunking Standard Approach to Monitoring Heart Disease

Read on to learn more about a recent Health Professional Radio interview, featuring Dr. James “Jim” K. Min.

Read More

1 min read

How to reduce heart attack rates

To reduce heart attack rates, make CCTA the new standard of care.

Read More

Cleerly Health hires new CRO

Hartman joins along with new COO and CTO.

Read More